Enovis (ENOV) Non-Current Debt (2010 - 2026)
Enovis' (ENOV) quarterly Non-Current Debt came in at $1.3 billion in Q2 2026, down 5.6% year-on-year from $1.4 billion in Q2 2025, and up 2.31% on a QoQ basis from $1.3 billion in Q4 2025.
Enovis (ENOV) Non-Current Debt (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Non-Current Debt data on file, last reported at $1.3 billion in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 5.6% year-over-year to $1.3 billion in Q2 2026; TTM through Apr 2026 was $1.3 billion, a 5.6% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 5.09% from the prior year.
- Non-Current Debt for Q2 2026 stood at $1.3 billion, up from $1.3 billion in the prior quarter.
- Over the last five years, Non-Current Debt for ENOV reached as high as $2.1 billion in Q2 2022 and fell as low as $40.0 million in Q4 2022.
- Historically, Non-Current Debt has averaged $973.3 million across 5 years, with a median of $1.3 billion in 2026.
- Across the five-year window, Non-Current Debt sank 98.08% in 2022 and surged 1065.41% in 2023, its largest moves.
- Year by year, Non-Current Debt stood at $40.0 million in 2022, then jumped by 1065.41% to $466.2 million in 2023, then soared by 185.2% to $1.3 billion in 2024, then dropped by 5.09% to $1.3 billion in 2025, then grew by 2.31% to $1.3 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $1.3 billion in Q2 2026, $1.3 billion in Q4 2025, and $1.4 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.29 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Oct 3, 2025 | 1.36 Bn |
| Jul 4, 2025 | 1.37 Bn |
| Apr 4, 2025 | 1.37 Bn |
| Dec 31, 2024 | 1.33 Bn |
| Sep 27, 2024 | 1.33 Bn |
| Jun 28, 2024 | 1.34 Bn |
| Mar 29, 2024 | 1.34 Bn |
| Dec 31, 2023 | 466.16 Mn |
| Sep 29, 2023 | 395.00 Mn |
| Jun 30, 2023 | 400.00 Mn |
| Mar 31, 2023 | 285.00 Mn |
| Dec 31, 2022 | 40.00 Mn |
| Sep 30, 2022 | 449.22 Mn |
| Jul 1, 2022 | 449.46 Mn |
| Apr 1, 2022 | 2.07 Bn |
| Dec 31, 2021 | 2.09 Bn |
| Oct 1, 2021 | 1.61 Bn |
| Jul 2, 2021 | 1.58 Bn |